CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
OkraVision aims to replace animal-derived high molecular weight hyaluronic acid with a plant-based alternative sourced from okra. This project focuses on developing a sustainable extraction and purification process for a non-animal substance, addressing market needs for safer and more reliable ophthalmic products.
Eye cataracts, leading to the loss of vision present a major problem for the aging population.
This is currently cured by surgical procedure which requires a viscoelastic High Molecular Weight (HMW) product of Ophthalmic Viscosurgical Device to fill the space in the eye created during the surgery and to protect the healthy endothelial cells.
Due to the growing elderly population, this market segment is expected to grow at least 7% per year and will reach €80 Mn in the EU and €240 Mn worldwide by…
BOHUS BIOTECH AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Norway, HAGAN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
United Kingdom, WORKSOP
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Sweden, GOTEBORG
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Estonia, TALLINN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
